Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans
about
sameAs
The Journal of Inflammation.NSAIDs: gastroprotection or selective COX-2 inhibitor?A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirinCOX-2 inhibitors compared and contrasted.Gastrointestinal side effects of NSAIDs - pharmacoeconomic implications.Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trialIncidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind studyRofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.Characterization of etoricoxib, a novel, selective COX-2 inhibitor.The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.
P2860
Q24806346-49C97C65-92CB-46A0-9959-1A65D6648815Q28168965-8A7FE6B8-9C43-4522-B7C6-001797396F2CQ33952053-4ADE134E-72B3-47DF-B357-A2F0EDE0DB10Q34515513-B23DE6B9-CCCB-4ED5-95BB-60C14FA42563Q34544721-3B2A0B00-7027-471A-9440-D2430136B015Q34548071-7268F8C1-2E08-4F29-81B5-C31F35AE89E9Q34722610-45E4F0E7-7FDD-4028-BC75-F2E8AA1C1189Q35080062-6017F03C-CFC4-4B4A-ACCC-2772E38A3F4AQ35195182-9771E1F6-71BB-4A63-B24C-7FEDCAF8424DQ35594930-80DA2FB2-5DCB-46EA-91CE-F98AFB33E6ECQ35595723-54D460E5-0C43-4AA5-93CB-64E272D64743Q39354736-B861E783-2411-474B-8B01-9034A0209AB7Q39382693-6579B9B4-BC50-4AEF-A61A-6A963DDB707CQ44484802-C32AEA2C-FE5C-452A-A4D2-0E37690D529AQ44542155-FDE1B61C-EA6C-4115-B816-30D94AEC64BAQ44813874-39495CAA-BEA9-49B2-8982-7D23B0B0A6FAQ45001564-89A171E0-A6DB-4B9F-A6EB-FABCF74D93ED
P2860
Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@ast
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@nl
type
label
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@ast
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@nl
prefLabel
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@ast
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@nl
P2093
P2860
P1476
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
P2093
P2860
P356
10.1046/J.1365-2036.2001.00894.X
P407
P577
2001-01-01T00:00:00Z